BCGM Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Buy
599
+12
+2% +$4.11K 0.05% 175
2026
Q1
$206K Sell
587
-37
-6% -$13.2K 0.05% 176
2025
Q4
$204K Buy
+624
New +$198K 0.05% 172
2024
Q4
Sell
-649
Closed -$209K 150
2024
Q3
$209K Buy
649
+2
+0.3% +$654 0.07% 151
2024
Q2
$202K Buy
+647
New +$190K 0.07% 147

Other funds holding AMGN

BCGM Wealth Management's AMGN Position: Q2 2026 in Review

BCGM Wealth Management increased its Amgen (AMGN) stake by 2% in Q2 2026, buying an estimated $4.11K and bringing the position to 599 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #175.

BCGM Wealth Management first reported a position in AMGN in Q2 2024 and has held it in 5 quarters since. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BCGM Wealth Management held 599 shares of Amgen worth $217K as of Q2 2026.
  • BCGM Wealth Management bought 12 Amgen shares in Q2 2026, an estimated $4.11K.
  • Amgen made up 0.05% of BCGM Wealth Management's portfolio in Q2 2026, its #175 holding.
  • BCGM Wealth Management first reported a position in Amgen in Q2 2024 and has held it in 5 quarters since.
  • 3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BCGM Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.